Pharmacological Control of Output Flashcards
What three things determine stroke volume?
- preload - left ventricular end diastolic pressure
- afterload - pressure in the wall of the left ventricle during ejection
- inotropy - contractility
What determines contractility?
Ca2+
What are inotopic drugs?
positive inotropic drugs = increase Ca = increase heart rate
negative inotropic drugs eg verapamil
What are the three types of inotropic drugs?
- cardiac glycosides
- sympathomimetics
- phosphodiesterase inhibitors
What is an example of a cardiac glycoside?
digitalis
found in foxgloves
What is the mechanism of digoxin?
inhibits Na/K ATPase = more Ca in cell = contraction increased
positive inotropism
it also blocks AV conduction, reducing HR by enhancing vagal nerve activity
What are uses of digoxin?
- permanent/persistent atrial fibrillation (not first line)
- first line for patients with AF who also have co-existing heart failure
- if heart failure is due to left ventricular dysfunction and condition has worsened even after using ACEi, diuretics and beta blockers
What are signs and symptoms of digoxin toxicity?
- bradycardia
- arrhythmia
- nausea, vomiting
- confusion
- visual disturbances
What is the dosing for digoxin?
- high initial loading dose 5mcg/kg of lean body weight
- maintenance dose calculated adjusted for renal function
What is the monitoring for digoxin?
- to make toxicity isnt developing
- monitor urea and electrolytes
Where are the a-receptors, b1-receptors and b2-receptors and what is their action?
a-receptors: in vasculature, agonists cause vasoconstriction
b1-receptors: expressed in heart, agonists are positively chronotropic
b2-receptors: vasculature, agonists cause vasodilatation
Describe the use of dopamine
medium dose: b1 tachycardia and increased contraction
large doses: a effects = peripheral vasoconstriction
it is a sympathomimetic
What is the function of Ad and NAd?
Ad: acts on all three receptors
used in cardiac arrest = peripheral vasoconstriction (a effects) and strong positive chronotropia (b1 effects)
NAd: a adrenoreceptor agonist -vasoconstrictor action
Talk about the use of phosphodiesterase inhibitors.
rarely used in clinical practise trials - increase in risk of mortality
used only in severe HF
eg enoximone
Whats the mechanism for phosphodiesterase inhibitors?
increase cAMP - increased contractility and heart rate
cAMP broken down by PDE
phospodiesterase inhibits breakdown of cAMP